background phase study conducted treatment stage cell lung cancer nsclc NUMBER NUMBER determine optimal dose basis results phase ii study using regimen fractions NUMBER week performed purpose present study determine local control survival rates methods december NUMBER november NUMBER NUMBER patients NUMBER primary lesions treated using fixed dose NUMBER gye stage ia nsclc NUMBER gye stage ib nsclc fractions NUMBER week primary tumors irradiated carbon beams average age patients NUMBER years NUMBER patients medically inoperable local control survival determined using method data statistically processed using test results patients observed minimum NUMBER years death median time NUMBER months ranging NUMBER NUMBER months local control rate patients NUMBER t1 NUMBER t2 NUMBER patients lung survival rate NUMBER ia NUMBER ib NUMBER overall survival NUMBER ia NUMBER ib NUMBER half deaths attributable intercurrent diseases toxic reactions lung greater grade NUMBER detected conclusion carbon ion beam radiotherapy regimen fractions NUMBER week proven valid alternative surgery stage nsclc offer particular benefits especially elderly inoperable patients non small NUMBER year kaplan meier log rank follow NUMBER year cancer specific ii